


Ask a doctor about a prescription for PHYSIONEAL 40 1.36% GLUCOSE SOLUTION FOR PERITONEAL DIALYSIS, CLEAR-FLEX
Package Leaflet: Information for the User
PHYSIONEAL 40 Glucose 1.36% w/v/ 13.6 mg/ml CLEAR-FLEX, Solution for Peritoneal Dialysis
PHYSIONEAL 40 Glucose 2.27% w/v/ 22.7 mg/mlCLEAR-FLEX, Solution for Peritoneal Dialysis
PHYSIONEAL 40 Glucose 3.86% w/v/ 38.6 mg/mlCLEAR-FLEX, Solution for Peritoneal Dialysis
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
PHYSIONEAL 40 is a solution for peritoneal dialysis. It removes water and waste products from the blood. It also corrects abnormal levels of various blood components. PHYSIONEAL 40 contains different concentrations of glucose (1.36%, 2.27% or 3.86%). The more glucose the solution contains, the more water will be removed from the blood.
PHYSIONEAL 40 may be prescribed for you if you have:
The PHYSIONEAL 40 solution has an acidity (pH) similar to that of blood. For this reason, it may be particularly useful if you experience discomfort or pain during the administration of other, more acidic peritoneal dialysis solutions.
Your doctor should supervise the administration of this product if it is the first time you are using it.
Do not use PHYSIONEAL 40
Treatment with PHYSIONEAL 40 in its CLEAR FLEX packaging is not recommended in some cases:
Warnings and precautions
Before using it, you must:
Inform your doctor before using PHYSIONEAL 40.
Be particularly careful:
Children
If you are under 18 years of age, your doctor will carefully evaluate the benefits and risks of using this product.
Using other medicines and PHYSIONEAL 40
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. The use of Physioneal is not recommended during pregnancy or breastfeeding unless your doctor advises you to do so.
Driving and using machines
This treatment can cause weakness, blurred vision, or dizziness. Do not drive or use machines if you are affected.
PHYSIONEAL 40 should be administered into your peritoneal cavity. This cavity is located in the abdomen (belly) between the skin and the peritoneum. The peritoneum is the membrane that surrounds the internal organs, such as the intestines or liver.
Do not use intravenously
Follow exactly the administration instructions of this medicine indicated by your specialized medical team in peritoneal dialysis. If in doubt, consult them again.
If the bag is damaged, it should be discarded.
Dose and frequency
Your doctor will indicate the appropriate glucose concentration and the number of bags you should use each day.
Use in children and adolescents
If you are under 18 years of age, your doctor will carefully evaluate the prescription of this medicine.
If you stop treatment with PHYSIONEAL 40
Do not stop peritoneal dialysis without your doctor's consent. Stopping treatment can have harmful consequences for your life.
Method of administration
Before use,
After use, check that the drainage fluid is not cloudy.
Compatibility with other medicines
Your doctor may prescribe other injectable medicines to be added directly to the PHYSIONEAL 40 bag. In this case, add the medicine through the medication addition site located in the large chamber, before opening the long seal. Disinfect the medication addition site immediately before proceeding with the injection. Use the product immediately after adding the medicine. Consult your doctor if you are unsure.
If you use more PHYSIONEAL 40 bags in 24 hours than you should
If you are given an excessive dose of PHYSIONEAL 40, you may experience:
Contact your doctor immediately. They will inform you of what to do.
If you have any other questions about the use of this product, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following situations, contact your doctor or peritoneal dialysis unit immediately:
These are serious side effects. You may need urgent medical attention.
If you experience any side effect, inform your doctor or peritoneal dialysis unit. This includes any side effect not listed in this leaflet.
Frequent (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Other side effects related to the peritoneal dialysis procedure:
Reporting of side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Discard PHYSIONEAL 40 as indicated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
This leaflet does not contain all the information about this medicine. If you have any doubts or are unsure about something, ask your doctor.
Composition of PHYSIONEAL 40
The mixed peritoneal dialysis solution contains the following active principles:
1.36% | 2.27% | 3.86% | |
Glucose monohydrate (g/l) | 15.0 | 25.0 | 42.5 |
Equivalent to anhydrous glucose (g/l) | 13.6 | 22.7 | 38.6 |
Sodium chloride (g/l) | 5.38 | ||
Calcium chloride dihydrate (g/l) | 0.184 | ||
Magnesium chloride hexahydrate (g/l) | 0.051 | ||
Sodium bicarbonate (g/l) | 2.10 | ||
Solution of (S)-sodium lactate equivalent to (S)-sodium lactate (g/l) | 1.68 |
The other components are water for injectable preparations, sodium hydroxide, and hydrochloric acid.
The composition in mmol/l of the mixed solution is:
1.36% | 2.27% | 3.86% | |
Anhydrous glucose (mmol/l) | 75.5 | 126 | 214 |
Sodium (mmol/l) Calcium (mmol/l) Magnesium (mmol/l) Chloride (mmol/l) Bicarbonate (mmol/l) Lactate (mmol/l) | 132 1.25 0.25 95 25 15 |
Appearance of the Product and Container Contents
PHYSIONEAL 40 is a colorless, transparent, and sterile solution for peritoneal dialysis.
PHYSIONEAL 40 is packaged in a PVC-free plastic bag with two chambers. The two chambers are separated by non-permanent seals. You should only perfuse PHYSIONEAL 40 when the solutions from the two chambers are fully mixed. Only then should you open the short seal (Safety Moon).
Each bag is wrapped in an overbag and supplied in a cardboard box.
Volume | Number of units per box | Product presentation | Types of connectors |
1.5 l | 5 / 6 | Single bag (DPA) | luer |
1.5 l | 5 / 6 | Double bag (DPCA) | luer |
2.0 l | 4 / 5 | Single bag (DPA) | luer |
2.0 l | 4 / 5 | Double bag (DPCA) | luer |
2.5 l | 3 / 4 | Single bag (DPA) | luer |
2.5 l | 3 / 4 | Double bag (DPCA) | luer |
3.0 l | 3 | Single bag (DPA) | luer |
3.0 l | 3 | Double bag (DPCA) | luer |
4.5 l | 2 | Single bag (DPA) | luer |
5.0 l | 2 | Single bag (DPA) | luer / luer and Line equipment with luer connection for DPA with HomeChoice |
Only some pack sizes may be marketed.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Marketing Authorization Holder
Vantive Health, S.L.
Polígono Industrial Sector 14
C/Pouet de Camilo 2
46394 Ribarroja del Turia (Valencia)
Spain
Manufacturer
Vantive Manufacturing Limited Moneen Road Castlebar County Mayo F23 XR63 Ireland or |
Bieffe Medital SpA, Via Nuova Provinciale 23034 Grosotto Italy |
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
Germany, Austria, Belgium, Bulgaria, Cyprus, Croatia, Denmark, Slovakia, Slovenia, Spain, Estonia, Finland, France, Greece, Netherlands, Hungary, Ireland, Iceland, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, United Kingdom (Northern Ireland), Czech Republic, Romania, Sweden: PHYSIONEAL 35 CLEAR-FLEX
Italy: FIXIONEAL 35
Date of the last revision of this leaflet: April 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Vantive, Physioneal, and Clear-Flex are registered trademarks of Vantive Health Inc. or its affiliates
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for PHYSIONEAL 40 1.36% GLUCOSE SOLUTION FOR PERITONEAL DIALYSIS, CLEAR-FLEX – subject to medical assessment and local rules.